Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 150 No. 0102 (2020)

Neonatal red blood cell transfusion practices in Switzerland: national survey and review of international recommendations

DOI
https://doi.org/10.4414/smw.2020.20178
Cite this as:
Swiss Med Wkly. 2020;150:w20178
Published
15.01.2020

Abstract

WHAT IS KNOWN ON THE SUBJECT? Red blood cell transfusions are frequently used in the care of newborns, particularly premature infants. Some countries have guidelines regarding preparation, indication and administration of red blood cells in newborns. There are no such guidelines in Switzerland.

WHAT DOES THE CURRENT STUDY ADD? This study analysed the results of two national surveys, one among blood transfusion services and the other among neonatal units in Switzerland. The results demonstrate considerable heterogeneity and a lack of “unité de doctrine”. Establishment of national guidelines would be helpful and warranted.

AIMS OF THE STUDY

The aim of the study was to analyse Swiss practices in blood transfusion services and neonatal units for the preparation and administration of red blood cells in newborns.

METHODS

Two questionnaires were developed and their results analysed. A first questionnaire was developed for the Swiss blood transfusion services and local hospital haematology laboratories, and a second for the neonatal units in Switzerland.

RESULTS

18/25 (72%) of laboratories and 26/29 (90%) of neonatal units performing red blood cell transfusions participated. Responses revealed a lack of consensus for the majority of questions. Differences were found in all steps of the process, from preparation (testing, irradiation, splitting, shelf life and storage of blood bags) to indication and administration (volume, speed, vascular access, patient monitoring) of red blood cells. Forty-six percent of neonatal units stated that they apply internal guidelines. Nevertheless, all but two would welcome the establishment of national recommendations.

CONCLUSION

This study confirmed the large variety in neonatal red blood cell transfusion practices in Switzerland. In the absence of clear evidence, national guidelines – as applied in other countries – would foster a common policy among Swiss neonatologists and facilitate the implementation of a national database for future research and comparison with international literature.

References

  1. Fabres J, Wehrli G, Marques MB, Phillips V, Dimmitt RA, Westfall AO, et al. Estimating blood needs for very-low-birth-weight infants. Transfusion. 2006;46(11):1915–20. doi:.https://doi.org/10.1111/j.1537-2995.2006.00997.x
  2. dos Santos AMN, Guinsburg R, Procianoy RS, Sadeck LS, Netto AA, Rugolo LM, et al.; Brazilian Network on Neonatal Research. Variability on red blood cell transfusion practices among Brazilian neonatal intensive care units. Transfusion. 2010;50(1):150–9. doi:.https://doi.org/10.1111/j.1537-2995.2009.02373.x
  3. Patel RM, Meyer EK, Widness JA. Research Opportunities to Improve Neonatal Red Blood Cell Transfusion. Transfus Med Rev. 2016;30(4):165–73. doi:.https://doi.org/10.1016/j.tmrv.2016.06.005
  4. ETTNO Investigators. The ‘Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth-Weight Infants (ETTNO)’ Study: Background, Aims, and Study Protocol. Neonatology. 2012;101(4):301–5. doi:.https://doi.org/10.1159/000335030
  5. Whyte RK, Jefferies AL ; Canadian Paediatric Society, Fetus and Newborn Committee. Red blood cell transfusion in newborn infants. Paediatr Child Health. 2014;19(4):213–17. doi:.https://doi.org/10.1093/pch/19.4.213
  6. Paul DA, Leef KH, Locke RG, Stefano JL. Transfusion volume in infants with very low birth weight: a randomized trial of 10 versus 20 ml/kg. J Pediatr Hematol Oncol. 2002;24(1):43–6. doi:.https://doi.org/10.1097/00043426-200201000-00012
  7. Patterson JA, Bowen JR, Francis S, Ford JB. Comparison of neonatal red cell transfusion reporting in neonatal intensive care units with blood product issue data: a validation study. BMC Pediatr. 2018;18(1):86. doi:.https://doi.org/10.1186/s12887-018-1005-2
  8. Howarth C, Banerjee J, Aladangady N. Red Blood Cell Transfusion in Preterm Infants: Current Evidence and Controversies. Neonatology. 2018;114(1):7–16. doi:.https://doi.org/10.1159/000486584
  9. von Lindern JS, Khodabux CM, Hack KEA, van Haastert IC, Koopman-Esseboom C, van Zwieten PHT, et al. Long-term outcome in relationship to neonatal transfusion volume in extremely premature infants: a comparative cohort study. BMC Pediatr. 2011;11(1):48. Available at: http://www.biomedcentral.com/1471-2431/11/48. doi:.https://doi.org/10.1186/1471-2431-11-48
  10. Fergusson DA, Hébert P, Hogan DL, LeBel L, Rouvinez-Bouali N, Smyth JA, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA. 2012;308(14):1443–51. doi:.https://doi.org/10.1001/2012.jama.11953
  11. Haute autorité de santé HAS. Recommandation de bonne pratique: Transfusion de globules rouges homologues: produits, indications, alternatives. Méthode Recommandations pour la pratique clinique. www.has-sante.fr/novembre 2014:46-60.
  12. Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten. 4. überarbeitete und aktualisierte Auflage 2014. http://www.bundesaerztekammer.de/aerzte/medizin-ethik/wissenschaftlicher-beirat/veroeffentlichungen/haemotherapie-transfusionsmedizin/querschnitt-leitlinie.
  13. New HV, Berryman J, Bolton-Maggs PHB, Cantwell C, Chalmers EA, Davies T, et al.; British Committee for Standards in Haematology. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol. 2016;175(5):784–828. doi:.https://doi.org/10.1111/bjh.14233
  14. National Blood Authority Australia. Patient Blood Management Guidelines: Module 6, Neonatal and Paediatrics 2016. https://www.blood.gov.au/pbm-guidelines.
  15. Blutspende SRK Schweiz. Transfusionsmedizin, Vorschriften. http://www.blutspende.ch/de/medizin/transfusionsmedizin/vorschriften.
  16. Blutspende SRK Schweiz. Transfusionsmedizinische Laboruntersuchungen an Patientenproben TL. 6.0 ed. Bern: Blutspende SRK Schweiz; 2017.
  17. Blutspende SRK Schweiz. Regionale Blutspendedienste. http://www.blutspende.ch/de/blutspende/kontakt/blutspende_regionale_blutspendedienste.
  18. Swissmedic, by arrangement with the Council of Europe. Optimaler Einsatz von Blut, Zusammenfassung der Produkteigenschaften. Swissmedic. 2016. https://www.swissmedic.ch/marktueberwachung/00138/00982/index.html.
  19. Roth-Kleiner M, Pfister R. Einteilung der neonatologischen Abteilungen in der Schweiz. Paediatrica. 2013;24(1):31.
  20. Swiss Society of Neonatology. Swiss neonatology units accredited to train neonatologists. http://www.neonet.ch/en/unit accreditation/accredited neonatology units 2018.
  21. Derek N. Handbook of Transfusion Medicine. 5th edition ed. Norwich: United Kingdom Blood Services; 2013: pp 120–4.
  22. European Committee on Blood Transfusion. Guide to the preparation, use and quality assurance of blood components, 18th Edition. Strasbourg: European Directorate for the Quality of Medicines and HealthCare; 2015; pp 118–22,343–61.
  23. Guillén U, Cummings JJ, Bell EF, Hosono S, Frantz AR, Maier RF, et al. International survey of transfusion practices for extremely premature infants. Semin Perinatol. 2012;36(4):244–7. doi:.https://doi.org/10.1053/j.semperi.2012.04.004
  24. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016;316(19):2025–35. doi:.https://doi.org/10.1001/jama.2016.9185
  25. Venkatesh V, Khan R, Curley A, Hopewell S, Doree C, Stanworth S. The safety and efficacy of red cell transfusions in neonates: a systematic review of randomized controlled trials. Br J Haematol. 2012;158(3):370–85. doi:.https://doi.org/10.1111/j.1365-2141.2012.09180.x
  26. Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, et al., for the PINT investigators. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301–7.e3. doi:.https://doi.org/10.1016/j.jpeds.2006.05.011
  27. Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, et al.; PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009;123(1):207–13. doi:.https://doi.org/10.1542/peds.2008-0338
  28. Whyte R, Kirpalani H. Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev. 2011;(11):CD000512. doi:.https://doi.org/10.1002/14651858.CD000512.pub2
  29. Kirpalani H, Bell E, D'Angio C, Hintz S, Kennedy K, Ohls R, et al. Protocol: Transfusion of Prematures (TOP) trial. Does a liberal red blood cell transfusion strategy improve neurologically-intact survival of extremely-low-birth-weight-infants as compared to a restrictive strategy? ClinicalTrials.gov;2012:NCT01702805
  30. Stainsby D, Jones H, Wells AW, Gibson B, Cohen H ; SHOT Steering Group. Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. Br J Haematol. 2008;141(1):73–9. doi:.https://doi.org/10.1111/j.1365-2141.2008.07022.x

Most read articles by the same author(s)